These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25549643)

  • 41. When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?
    Bangalore S; Kumar S; Messerli FH
    Congest Heart Fail; 2013; 19(3):107-15. PubMed ID: 23241032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium tanshinone ⅡA sulfonate injection as adjunctive therapy for the treatment of heart failure: A systematic review and meta-analysis.
    Shao H; Fang C; Huang Y; Ye Y; Tong R
    Phytomedicine; 2022 Jan; 95():153879. PubMed ID: 34906894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
    Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JF; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Manfreda VM; Gentile G; Strippoli GF
    Nephrol Dial Transplant; 2011 Sep; 26(9):2827-47. PubMed ID: 21372254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
    Wen J; Ma X; Zhang L; Lu X; Yang Y; Wang J; Zhao Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13580. PubMed ID: 30572460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A meta-analysis of the effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on insulin sensitivity in hypertensive patients without diabetes.
    Yang Y; Wei RB; Wang ZC; Wang N; Gao YW; Li MX; Qiu Q
    Diabetes Res Clin Pract; 2015 Mar; 107(3):415-23. PubMed ID: 25649909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure.
    Liang Y; Pan W; Su Y; Ge J
    Am J Cardiol; 2011 Oct; 108(8):1160-5. PubMed ID: 21813108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
    Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
    Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
    Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chaugai S; Meng WY; Ali Sepehry A
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial.
    Yan P; Fan W;
    Clin Exp Hypertens; 2014; 36(4):268-74. PubMed ID: 23859303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of moxibustion combined with benazepril on expression of IL-18 and phosphorylated protein kinase B in myocardial tissue of rats with chronic heart failure].
    Wang W; Li QL; Ma Q; Xia R; Gao B; Wang Y; Wang J
    Zhen Ci Yan Jiu; 2021 Nov; 46(11):935-41. PubMed ID: 34865330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Liu Y; Teramoto K; Wing VK; Supasiri T; Yin K
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):371-378. PubMed ID: 33404924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.
    McAlister FA;
    Eur Heart J; 2012 Feb; 33(4):505-14. PubMed ID: 22041554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension.
    Zhenfeng Zheng ; Huilan Shi ; Junya Jia ; Dong Li ; Shan Lin
    J Renin Angiotensin Aldosterone Syst; 2011 Jun; 12(2):102-12. PubMed ID: 21059822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Meta analysis of the efficacy and safety of combined treatment with ARB and ACEI on diabetic kidney disease].
    Gu J; Han L; Liu Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):623-30. PubMed ID: 23828705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A systematic review and meta-analysis on efficacy and safety of cardiac resynchronization therapy alone or in combination with implantable cardioversion defibrillation in patients with mild to severe heart failure].
    Tu RH; Peng RL; Zhong GQ; Wu WF; Chen L; Liang YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):161-70. PubMed ID: 23710749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.